CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-07 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2025-01-20 | McMichael Bryan J Chief Financial Officer | Shares withheld for taxes | −1,711 | $1.39 | $2K | 22,951 |
| 2025-01-20 | Reider Paul Chief Commercial Officer | Shares withheld for taxes | −4,858 | $1.39 | $7K | 82,069 |
| 2025-01-20 | Lanfear Dennis M President & CEO | Shares withheld for taxes | −11,810 | $1.39 | $16K | 685,074 |
| 2025-01-10 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +575,000 | 575,000 | ||
| 2025-01-07 | McMichael Bryan J Chief Financial Officer | Shares withheld for taxes | −1,711 | $1.57 | $3K | 24,662 |
| 2025-01-04 | Lanfear Dennis M President & CEO | Shares withheld for taxes | −11,810 | $1.66 | $20K | 696,884 |
| 2025-01-04 | Reider Paul Chief Commercial Officer | Shares withheld for taxes | −2,277 | $1.66 | $4K | 86,927 |
| 2025-01-03 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2025-01-03 | Reider Paul Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-12-13 | Reider Paul Chief Commercial Officer | Shares withheld for taxes | −2,073 | $1.61 | $3K | 89,204 |
| 2024-08-07 | McMichael Bryan J Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2024-07-22 | Lanfear Dennis M President & CEO | Grant or award · Stock Option (Right to Buy) | +196,500 | 196,500 | ||
| 2024-07-22 | Reider Paul Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-06-04 | Karachun Rita A Director | Grant or award · Stock Option (Right to Buy) | +168,000 | 168,000 | ||
| 2024-06-04 | Erbez Georgia Director | Grant or award · Stock Option (Right to Buy) | +114,000 | 114,000 | ||
| 2024-06-03 | Newton Charles W. Director | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2024-06-03 | Ryan Michael Lee Director | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2024-06-03 | Wahlstrom Mats Director | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2024-06-03 | STOLPER MARK Director | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 |
Page 4 of 39 · 768 trades